The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
COMy 2022 | How has the role of transplant changed with the introduction of CAR-T therapy?
Michele Cavo, MD, PhD, Bologna University School of Medicine, Bologna, Italy, shares some insights into how the role of transplantation has changed with the introduction of CAR-T therapy. Prof. Cavo explains that head-to-head comparison trials are still needed to evaluate CAR-T versus transplant upfront, and also mentions the promise that CAR-T therapy has provided for high-risk patients and those with relapsed disease. This interview took place at the 8th World Congress on Controversies in Multiple Myeloma (COMy) 2022, held in Paris, France.
